255 related articles for article (PubMed ID: 12438622)
1. RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication.
Surabhi RM; Gaynor RB
J Virol; 2002 Dec; 76(24):12963-73. PubMed ID: 12438622
[TBL] [Abstract][Full Text] [Related]
2. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
4. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
[TBL] [Abstract][Full Text] [Related]
6. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.
Williams SA; Kwon H; Chen LF; Greene WC
J Virol; 2007 Jun; 81(11):6043-56. PubMed ID: 17376917
[TBL] [Abstract][Full Text] [Related]
7. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
Xie B; Wainberg MA; Frankel AD
J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
[TBL] [Abstract][Full Text] [Related]
8. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
Zhu M; Duan L; Pomerantz RJ
AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
[TBL] [Abstract][Full Text] [Related]
9. Herpesvirus saimiri terminal membrane proteins modulate HIV-1 replication by altering Nef and Tat functions.
Raymond AD; Hasham M; Tsygankov AY; Henderson EE
Curr HIV Res; 2007 Jan; 5(1):79-86. PubMed ID: 17266559
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
11. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.
Li X; Josef J; Marasco WA
Biochem Biophys Res Commun; 2001 Aug; 286(3):587-94. PubMed ID: 11511100
[TBL] [Abstract][Full Text] [Related]
12. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
[TBL] [Abstract][Full Text] [Related]
13. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
15. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
Liang C; Wainberg MA
AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
[TBL] [Abstract][Full Text] [Related]
16. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
17. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.
Ivanov D; Kwak YT; Nee E; Guo J; García-Martínez LF; Gaynor RB
J Mol Biol; 1999 Apr; 288(1):41-56. PubMed ID: 10329125
[TBL] [Abstract][Full Text] [Related]
18. Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.
Kameoka M; Rong L; Götte M; Liang C; Russell RS; Wainberg MA
J Virol; 2001 Mar; 75(6):2675-83. PubMed ID: 11222691
[TBL] [Abstract][Full Text] [Related]
19. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
Coburn GA; Cullen BR
J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
[TBL] [Abstract][Full Text] [Related]
20. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]